US Broker Ratings

Sotera Health Company (SHC) Stock Analysis: Healthcare Powerhouse with a 3.43% Potential Upside

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector, specializing in diagnostics and research, is catching the attention of investors with its robust..

Rhythm Pharmaceuticals, Inc. (RYTM): Analyst Consensus and Growth Potential Amidst a 32% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on rare neuroendocrine diseases. Known for its flagship product, IMCIVREE, designed to..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Pioneer with a Mixed Valuation Outlook

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, focusing on pioneering treatments for rare genetic diseases. Headquartered in Cambridge, Massachusetts,..

Inspire Medical Systems, Inc. (INSP): Investor Outlook with a 51.73% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a trailblazer in the healthcare sector, particularly within the medical devices industry, has garnered significant attention for its innovative approach..

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator with Nearly 100% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to vaccine development. Focused on addressing..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Investor Optimism

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a leading entity in the biotechnology sector, is making waves with its promising growth trajectory and innovative product offerings. With a..

Integer Holdings Corporation (ITGR) Stock Report: Analyst Consensus and Growth Potential

Integer Holdings Corporation (NYSE: ITGR) stands as a pivotal player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plano, Texas, and with..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling the 140% Upside Potential

Soleno Therapeutics, Inc. (SLNO) is positioning itself as a significant player in the biotechnology sector with a focus on developing treatments for rare diseases. Headquartered in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Buy Ratings and 51.25% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the healthcare sector as a dynamic player in the biotechnology industry. With a market capitalization of $4.65 billion,..

Axsome Therapeutics (AXSM) Stock Analysis: Revenue Growth Soars Amid Biotech Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands as a compelling figure in the biotechnology sector, captivating investor attention with its impressive 63.20% revenue growth amidst the challenges..

Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a leader in the healthcare sector focused on ophthalmic pharmaceuticals and medical technology, is capturing investor attention with an enticing potential upside..

Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors seeking exposure to innovative patient..

Alkermes plc (ALKS) Stock Analysis: Unveiling a 55% Upside Potential for Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector and a key figure in the specialty and generic drug manufacturing industry, presents a compelling..

Bausch + Lomb Corporation (BLCO): Investor Outlook on Growth Potential and Strategic Positioning

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 10.44% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its innovative RNA-targeted medicines. With a market..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside in Biotech Innovation

Investors searching for opportunities in the biotechnology sector might find Akero Therapeutics, Inc. (NASDAQ: AKRO) an intriguing prospect. This South San Francisco-based company, with a market..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring the 362% Revenue Growth Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with its remarkable 362% revenue growth. As a biopharmaceutical company focused on novel therapeutics for..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 20% Upside Potential Amidst Healthcare Innovations

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector and a pivotal player in the medical devices industry, is capturing investor attention with a potential..

Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Ratings and 13.5% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) is capturing the attention of investors with its robust growth prospects and strong analyst support. This healthcare company, headquartered in Palo..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 19.84% Upside Potential Amid Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the medical instruments and supplies industry, is capturing investor attention with its promising growth prospects. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds